Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KARDthis companyKardigan, Inc.	$15.84	-6.88×	-5.27×	0×	-6.24×	-89.5%	0.0%	0.0%	0.0%	76.7%	-55.3%	-12.0%	-0.06×	0.49×	0×	9.2×	0.0%	—	—	2	C
BRBRVEBraveheart Bio, Inc.	$19.29	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
CYTKCytokinetics, Incorporated	$53.79	-9.72×	-11.56×	86.62×	-11.34×	-204.0%	88.5%	-695.4%	-891.6%	119.0%	-47.7%	-7.0%	-1.95×	-1.5×	-5.89×	4.53×	0.0%	1	-1.09	2	C
IKTInhibikase Therapeutics, Inc.	$1.61	-4.18×	1.17×	0×	-1.17×	-8.7%	0.0%	0.0%	0.0%	-27.9%	-30.1%	-13.8%	0×	2.61×	0×	21.7×	0.0%	2	10.89	2	C
RNAAtrium Therapeutics, Inc.	$8.30	-3.29×	1.22×	13.56×	0.18×	-203.3%	100.0%	-412.6%	-411.9%	-37.0%	-31.9%	-16.9%	0.02×	3.48×	0×	6.53×	0.0%	—	—	2	C+
TNYATenaya Therapeutics, Inc.	$0.41	-1.21×	0.88×	0×	-0.23×	56.9%	0.0%	0.0%	0.0%	-73.5%	-69.4%	-63.3%	0.09×	1.09×	0×	6.84×	0.0%	3	-10.71	3	B-
Peer median	—	-3.74×	1.02×	6.78×	-0.7×	-106.0%	44.2%	-206.3%	-205.9%	-32.5%	-39.8%	-15.3%	0.01×	1.85×	0×	6.68×	0.0%	2	-1.09	2	—